Drug intelligence / Profile preview

Yining Pills

Development stage
Unknown
Lead developer
Beijing Hospital of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Yining Pills (怡宁丸) is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Beijing Hospital of Traditional Chinese Medicine, affiliated with Capital Medical University. It is specifically indicated for the treatment of chronic insomnia, particularly cases associated with TCM patterns such as heart-spleen deficiency or liver-qi stagnation. The formulation is a complex mixture of herbs, including *Ziziphus jujuba* var. *spinosa* (Suan Zao Ren), *Poria cocos* (Fu Ling), and *Polygala tenuifolia* (Yuan Zhi), which are traditionally used to nourish the heart, calm the spirit (Anshen), and regulate the flow of Qi. As a hospital-made preparation (院内制剂), its clinical use is generally restricted to the developing institution and its medical network under specific regulatory approvals for TCM hospital formulas in China. It is recognized for its ability to improve sleep latency and quality with a favorable safety profile compared to synthetic sedative-hypnotics.

Brand names
Yining Pills
Other names
Yining Wan怡宁丸
02

Targets

GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)5-HT (Serotonin receptors)

Beyond the preview

Go deeper on Yining Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yining Pills.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call